Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A



Status:Archived
Conditions:Anemia, Hematology
Therapuetic Areas:Hematology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:May 2010
End Date:October 2012

Use our guide to learn which trials are right for you!

Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of Human-cl rhFVIII, a Newly Developed Human Cell-line Derived Recombinant FVIII Concentrate in Previously Treated Patients With Severe Hemophilia A


This is a clinical study to investigate the pharmacokinetics, efficacy, safety and
immunogenicity of human-cl rhFVIII, a newly developed human cell-line derived recombinant
FVIII concentrate in previously treated patients with severe Hemophilia A.



We found this trial at
7
sites
Milwaukee, Wisconsin 53201
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
4000 Reservoir Road NW, Suite 120
Washington, Washington DC 20007
(202) 687-0100
Georgetown Univ Med Ctr Georgetown University Medical Center is committed to excellence in research, education...
?
mi
from
Washington, DC
Click here to add this to my saved trials
Boulder, Colorado 80309
(303) 492-1411
University of Colorado, Boulder As the flagship university of the state of Colorado, CU-Boulder is...
?
mi
from
Boulder, CO
Click here to add this to my saved trials
1653 W. Congress Parkway
Chicago, Illinois 60612
(312) 942-5000
Rush University Medical Center Rush University Medical Center encompasses a 664-bed hospital serving adults and...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Los Angeles, California 90007
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Orange, California 92868
?
mi
from
Orange, CA
Click here to add this to my saved trials